Therapeutic Drug Monitoring companies

  • Report ID: 742
  • Published Date: Jun 27, 2025
  • Report Format: PDF, PPT

Key Therapeutic Drug Monitoring Market Players:

    The global therapeutic drug monitoring market is dominated by various giant players, including Roche, Abbott, and Thermo Fisher. These players use advanced platforms such as LC-MS/MS, AI-enhanced analyzers, and hospital-integrated digital solutions to lead the market share. Further the top players in Europe, such as Siemens Healthineers and Theradiag, lead in biotherapeutic monitoring, whereas companies in India and Japan provide affordable and customized diagnostics to regional demand. Many market players concentrate on miniaturization, value-based care alignment, and automation to meet the demand.

    The top 20 cohort of such key players includes: 

    Company Name

    Country of Origin

    Key Focus

    Estimated Market Share (%) – 2037

    Roche Diagnostics

    Switzerland

    Immunoassays, analyzers (Cobas)

    13.7%

    Thermo Fisher Scientific

    USA

    LC-MS/MS, high-throughput diagnostics

    11.9%

    Abbott Laboratories

    USA

    Architect & Alinity platforms

    11.2%

    Siemens Healthineers

    Germany

    Atellica, precision diagnostics

    10.4%

    Beckman Coulter (Danaher)

    USA

    Clinical analyzers, drug assay panels

    6.9%

    Bio-Rad Laboratories

    USA

    Quality control systems, TDM reagents

    xx%

    Randox Laboratories

    UK

    Biochip array tech, immunoassays

    xx%

    Agilent Technologies

    USA

    Mass spectrometry platforms

    xx%

    Chromsystems GmbH

    Germany

    LC-MS/MS reagents for hospitals

    xx%

    Sekisui Medical Co., Ltd.

    Japan

    Immunoassay reagents, enzyme kits

    xx%

    ARK Diagnostics, Inc.

    USA

    TDM kits for epilepsy, pain, depression

    xx%

    Nova Biomedical

    USA

    Blood-based analyzers for critical care

    xx%

    Tosoh Bioscience

    Japan

    Automated analyzers (AIA series)

    xx%

    Theradiag

    France

    Biologics & biosimilar drug monitoring

    xx%

    Sysmex Corporation

    Japan

    Middleware, informatics for TDM

    xx%

    Alere Inc. (Now Abbott)

    USA

    POCT solutions for drug monitoring

    xx%

    Horiba Medical

    France

    Mid-sized diagnostic analyzers

    xx%

    Sonic Healthcare

    Australia

    Lab services, pathology-based drug testing

    xx%

    Transasia Bio-Medicals Ltd.

    India

    ELISA kits, immunoassay-based TDM

    xx%

    LabCorp (Laboratory Corporation of America)

    USA

    Clinical diagnostics & reference lab services

    xx%

    Below are the areas covered for each company in the therapeutic drug monitoring market:

    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of therapeutic drug monitoring is evaluated at USD 2.6 billion.

Therapeutic Drug Monitoring Market size was valued at USD 2.5 billion in 2024 and is set to exceed USD 4.9 billion by 2037, expanding at over 6.1% CAGR during the forecast period i.e., between 2025-2037.

North America industry is anticipated to account for largest 40.2% revenue share by 2037, on account of presence of leading players in the region.

The major players in the market are Abbott, Thermo Fisher Scientific Inc., Siemens Healthcare Private Limited, Bio-Rad Laboratories, Inc., Randox Laboratories Ltd., Sekisui Medical Co., Ltd., OraSure Technologies, Inc., Beckman Coulter, Inc., among others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos